Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Preferred Stock was decided 1997
Reply New Message
Prev Message Back To Forum Threaded View Next Message

The "Risk" lies with us, not them... I can't help but to think this will be in an effort to backdoor all the common shareholders. No wonder this bastards don't own any meaningful amounts of common shares.

13 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply